海王英特龙(08329)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08329 海王英特龙

休市中 09-25 09:00:01

0.094

+0.000

0.00%

最高0.094	最低0.094	成交量0.00
今开0.094	昨收0.094	日振幅0.00%
总市值1.58亿	流通市值4,004万	总股本16.78亿
成交额0.00	换手率0.00%	流通股本4.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08329","market":"HK","secType":"STK","nameCN":"海王英特龙","latestPrice":0.094,"timestamp":1790298001025,"preClose":0.094,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":426000000,"shares":1678000000,"eps":-0.028337960704341345,"marketStatus":"休市中","change":0,"latestTime":"09-25 09:00:01","open":0.094,"high":0.094,"low":0.094,"amount":0,"amplitude":0,"askPrice":0.095,"askSize":40000,"bidPrice":0.087,"bidSize":220000,"shortable":0,"etf":0,"ttmEps":-0.03662127489705479,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":7,"adr":0,"listingDate":1126454400000,"exchange":"SEHK","adjPreClose":0.094,"openAndCloseTimeList":[[1790299800000,1790308800000],[1790312400000,1790323200000]],"volumeRatio":0,"lotSize":10000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08329","defaultTab":"news","newsList":[{"id":"2667650340","title":"海王英特龙(08329.HK)附属海王长健与慧康生物就成立一家合营公司订立《合资经营协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667650340","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667650340?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:40","pubTimestamp":1789382431,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156611222","title":"海王英特龙（08329）拟出资350万元与慧康生物组建合营公司 进军肿瘤早筛与IVD领域","url":"https://stock-news.laohu8.com/highlight/detail?id=1156611222","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156611222?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:31","pubTimestamp":1789381900,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司9月14日晚间公告称，其全资子公司深圳海王长健医药有限公司已与深圳市慧康生物技术有限公司签署《合资经营协议》，拟共同出资设立一家主攻肿瘤早筛及体外诊断产品与解决方案的有限责任公司。双方承诺自合营公司完成工商注册之日起一年内完成实缴出资。海王英特龙表示，此次合作将整合双方在研发、产品及渠道资源，助力肿瘤早筛与IVD技术的转化与商业化，丰富集团产品线并提升市场覆盖率。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115247470","title":"海王英特龙携手合资，深耕早期癌症筛查与体外诊断领域","url":"https://stock-news.laohu8.com/highlight/detail?id=1115247470","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115247470?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:27","pubTimestamp":1789381629,"startTime":"0","endTime":"0","summary":"海王英特龙生物技术公司宣布，将组建一家合资企业，专注于早期癌症筛查及体外诊断业务。这一战略举措标志着该公司在精准医疗领域的纵深布局，旨在抢占日益增长的市场机遇。合资企业将整合多方资源，致力于开发创新检测技术与产品，以提升癌症早期发现率，满足临床需求。此举也反映出行业对预防性医疗解决方案的持续关注，以及企业在价值链上寻求更高附加值的努力。通过强化研发能力和市场渠道，海王英特龙期望在诊断领域建立显著优势，为未来增长注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102376455","title":"海王英特龙：子公司与惠康生物技术达成合资协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1102376455","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102376455?lang=zh_cn&edition=full","pubTime":"2026-09-14 18:27","pubTimestamp":1789381628,"startTime":"0","endTime":"0","summary":"海王英特龙（NEP INTERLONG）近日宣布，其下属子公司已与惠康生物技术正式签署合资协议。此举标志着双方在生物科技领域的深度合作迈出关键一步。此次合资协议的达成，不仅彰显了海王英特龙在战略布局上的前瞻性，也为惠康生物技术的业务拓展注入了新的活力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116579678","title":"海王英特龙8月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1116579678","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116579678?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:46","pubTimestamp":1788255996,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司于2026年9月1日发布截至2026年8月31日的证券变动月报表。报告显示，公司2026年8月期间未发生新增发行、购回、注销或库藏股等变动情况，股本保持稳定。公司确认满足香港联交所适用的公众持股量要求。截至本月底，公司总已发行股份数保持不变，股本结构整体稳定。公司表示，后续将在严格遵守香港联交所《上市规则》及相关法律法规的前提下，持续做好信息披露工作。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120736472","title":"海王英特龙（08329）控股股东被责令六个月内归还占用资金","url":"https://stock-news.laohu8.com/highlight/detail?id=1120736472","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120736472?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:17","pubTimestamp":1788167877,"startTime":"0","endTime":"0","summary":"2026年8月31日，深圳市海王英特龙生物技术股份有限公司发布自愿性公告称，其控股股东深圳市海王生物工程股份有限公司已收到中国证券监督管理委员会深圳监管局下发的《监管决定书》。监管决定书要求海王生物及其控股股东采取“责令改正”的监管措施。公司董事会提醒投资者关注海王生物将于2026年8月28日晚间披露的相关公告详情，并在买卖公司股份时保持审慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663407613","title":"海王英特龙：控股股东收到深圳证监局责令改正监管决定书","url":"https://stock-news.laohu8.com/highlight/detail?id=2663407613","media":"南方财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663407613?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:06","pubTimestamp":1788167160,"startTime":"0","endTime":"0","summary":"南财智讯8月31日电，海王英特龙（08329.HK）发布自愿公告，本公司控股股东深圳市海王生物工程股份有限公司收到中国证券监督管理委员会深圳监管局出具的监管决定书，决定对海王生物及其控股股东采取责令改正的监管措施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860145238.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860145238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103887219","title":"海王英特龙：被占用资金限期六个月归还 并向深圳证监局提交报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1103887219","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103887219?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:05","pubTimestamp":1788167109,"startTime":"0","endTime":"0","summary":"海王英特龙生物技术公司今日公告，相关被占用资金须在六个月内悉数归还，同时需向中国证监会深圳监管局呈交详细报告。这一举措，无疑给市场吃下了一颗定心丸。公司方面承诺，将严格依照监管要求，确保资金归位流程规范透明。此次整改动作，折射出监管层对上市公司资金使用合规性的高度重视。六个月的时限，既是压力也是动力，考验着公司内部的治理效能与执行力。后续进展，市场将保持密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731424","title":"海王英特龙(08329)发布中期业绩 股东应占溢利704.2万元 同比减少63.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731424","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662731424?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:50","pubTimestamp":1787658601,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海王英特龙(08329)发布截至2026年6月30日止六个月的中期业绩，集团收入人民币4.36亿元，同比减少12.05%;股东应占溢利704.2万元，同比减少63.06%;每股亏损0.42分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195848205","title":"海王英特龙2026年上半年营收4.36亿元，经调整净利润891万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195848205","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195848205?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:42","pubTimestamp":1787658168,"startTime":"0","endTime":"0","summary":"海王英特龙发布的2026年中期报告显示，报告期内实现营收4.36亿元，同比下降12.05%。本期经调整净利润891万元，同比下降59.57%。报告期内，销售及分销开支约5,865万元，同比减少20.88%；管理费用约4,544万元，与上年同期基本持平；研发投入约1,415万元，较上年同期有所降低。报告期内，药品及医疗器械生产销售分部实现收入2.17亿元，约占总营收的49.71%；药品、保健品及医疗器械的采购与分销分部实现收入2.19亿元，约占总营收的50.29%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"海王英特龙2026年上半年营收4.36亿元，经调整净利润891万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110985433","title":"海王英特龙（08329）发布2026年中期业绩：营收4.36亿元净利降至8910万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110985433","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110985433?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:35","pubTimestamp":1787657744,"startTime":"0","endTime":"0","summary":"2026年8月25日，海王英特龙生物技术股份有限公司披露截至2026年6月30日止六个月未经审核中期业绩。报告期内，公司主营业务仍为药品及医疗器械的研发、生产与销售，以及药品、保健品和医疗器械的采购与分销。主要经营及财务数据如下：。－ 营业收入为4.36亿元，同比下降12.05%。生产及销售药品及医疗器械实现收入2.17亿元，占比49.71%，同比减少13.62%。－ 期内净利润为8910万元，同比下降59.57%；其中归属于公司股东的净利润为7042万元，同比下降63.06%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658789389","title":"海王英特龙：2026年中期净利润约人民币700万元 同比下降约63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658789389","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658789389?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:52","pubTimestamp":1786524740,"startTime":"0","endTime":"0","summary":"南财智讯8月12日电，海王英特龙（08329.HK）发布盈利预警公告，预计公司2026年中期（截至2026年6月30日止六个月）归属于本公司拥有人的净利润约人民币700万元，较2025年同期的约人民币1907万元下降约63%。下降主要因市场环境及政策影响，集团收入下降约12%，其中药品及医疗器械生产与销售分部收入减少所致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608123839201978.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608123839201978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189145058","title":"海王英特龙（08329）发布盈利预警：2026年中期归母净利预计约700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189145058","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189145058?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:51","pubTimestamp":1786524717,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司（08329）8月12日公告称，依据截至2026年6月30日止六个月的未经审计综合管理账目及现有资料，预计2026年中期归属于公司拥有人净利润约为人民币700万元。对比2025年同期录得的约人民币1,907万元，净利润预计减少约人民币1,207万元，降幅约63.30%。\n公司表示，业绩下滑的主要原因是受市场环境及政策影响，集团收入同比下降约12%，其中以药品及医疗器械生产和销售分部收入减少为主。\n海王英特龙计划于2026年8月25日公布2026年中期业绩。公司提醒股东及潜在投资者在买卖公司股份时保持审慎。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658773920","title":"海王英特龙(08329.HK)发盈警 预计中期净利润约700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658773920","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658773920?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:45","pubTimestamp":1786524343,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115424101","title":"海王英特龙预期2026年中期归母净利润达700万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1115424101","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115424101?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:45","pubTimestamp":1786524301,"startTime":"0","endTime":"0","summary":"海王英特龙（NEP INTERLONG）发布公告，预期公司在2026年中期期间，归属于所有者的净利润将达到700万元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191365265","title":"海王英特龙(08329)发布公告：董事会将于8月25日审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1191365265","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191365265?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:42","pubTimestamp":1786524177,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司（08329）8月12日公告称，董事会已排定于2026年8月25日11时正，在中国广东省深圳市南山区科技中三路1号海王银河科技大厦24楼会议室召开董事会会议。会议主要议程包括：\n1. 审议及批准本公司及其附属公司截至2026年6月30日止六个月的未经审计合并中期业绩，并确认将在香港联合交易所有限公司GEM网站及公司官网公布相关业绩公告；\n2. 考虑是否派发中期股息；\n3. 研究是否需要暂时停办股份过户登记；\n4. 讨论其他事项。\n公司披露，此次董事会由董事长张锋召集。公告已于香港联交所网站及公司官网同步刊载，有效期至少7日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144612108","title":"海王英特龙7月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1144612108","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144612108?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:25","pubTimestamp":1785835542,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司于2026年8月4日发布截至2026年7月31日止月份的股份变动月报表，披露报告期内公司股本维持稳定，未发生新增发行或股份变动。上述股本在7月期间无增加、减少或变动。此外，公司在报告期内亦不存在股份回购、注销、库藏股和其他发行承诺等活动，未涉及任何股份期权及股权激励计划变动。截至本月末，海王英特龙已发行股份总数仍为4.26亿股H股与12.52亿股内资股，股本总体保持平稳。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170212634","title":"海王英特龙6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1170212634","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170212634?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:17","pubTimestamp":1782983825,"startTime":"0","endTime":"0","summary":"深圳市海王英特龙生物技术股份有限公司于2026年7月2日披露截至2026年6月30日的证券变动月报表。报告显示，公司在本月内未有新增发行、购回、注销或库藏股情况，整体股本结构维持稳定。同时，H股及内资股于报告期内未发生新增或减少变动，H股数量依然为426,000,000股，内资股数量为1,252,000,000股，公司已发行股份总数未发生变化。本次公告由公司H股股份过户及登记处卓佳证券登记有限公司呈交。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158586313","title":"海王英特龙签署意向书 拟投资深圳基因健康","url":"https://stock-news.laohu8.com/highlight/detail?id=1158586313","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158586313?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:23","pubTimestamp":1782390194,"startTime":"0","endTime":"0","summary":"海王英特龙生物技术股份有限公司宣布，已就潜在投资深圳基因健康事宜签署了一份意向书。此举标志着公司正积极拓展其在生物技术领域的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08329","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646887004","title":"海王英特龙(08329.HK)拟以增发新股或受让现有股份的方式取得晋百慧部分股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2646887004","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646887004?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:22","pubTimestamp":1782390166,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","08329"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.interlong.com","stockEarnings":[{"period":"1week","weight":-0.06},{"period":"1month","weight":-0.1681},{"period":"3month","weight":-0.1132},{"period":"6month","weight":-0.2824},{"period":"1year","weight":-0.3816},{"period":"ytd","weight":-0.4088}],"compareEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.0446},{"period":"3month","weight":0.0811},{"period":"6month","weight":-0.0177},{"period":"1year","weight":-0.0746},{"period":"ytd","weight":-0.0437}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市海王英特龙生物技术股份有限公司是一家主要从事药品及医疗器械的研发、生产及销售，以及药品、保健食品及医疗器械购销的中国公司。该公司通过两个分部开展业务。生产及销售药品及医疗器械分部主要从事生产及销售药品，及医疗器械。销售及分销药品、保健品及医疗器械分部主要从事销售及分销药品，保健品及医疗器械。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.380952,"avgChangeRate":-0.031121},{"month":2,"riseRate":0.47619,"avgChangeRate":0.018781},{"month":3,"riseRate":0.285714,"avgChangeRate":0.04754},{"month":4,"riseRate":0.47619,"avgChangeRate":0.074568},{"month":5,"riseRate":0.380952,"avgChangeRate":-0.002642},{"month":6,"riseRate":0.333333,"avgChangeRate":0.013736},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.024673},{"month":8,"riseRate":0.428571,"avgChangeRate":0.019141},{"month":9,"riseRate":0.380952,"avgChangeRate":-0.014503},{"month":10,"riseRate":0.52381,"avgChangeRate":0.068079},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.044821},{"month":12,"riseRate":0.380952,"avgChangeRate":-0.009944}],"exchange":"SEHK","name":"海王英特龙","nameEN":"NEP INTERLONG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海王英特龙(08329)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海王英特龙(08329)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海王英特龙,08329,海王英特龙股票,海王英特龙股票老虎,海王英特龙股票老虎国际,海王英特龙行情,海王英特龙股票行情,海王英特龙股价,海王英特龙股市,海王英特龙股票价格,海王英特龙股票交易,海王英特龙股票购买,海王英特龙股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海王英特龙(08329)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海王英特龙(08329)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}